Clinical trial NCT05514899
Status: RecruitingPhase 2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
- Record number
- NCT05514899
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 2
- Participants
- Target: 90
- Condition (as registered)
- HIV, Neuroinflammatory Disease, Neuroinflammatory Response, Microbiome
- Countries
- United States
- Topic in the guide
- Outside the topics in the guide
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: September 1, 2023
- End of data collection for primary results: October 31, 2027 (expected)
- Trial completion: October 31, 2027 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Thinking of taking part? Which specialist to see